Pagina 3 - I migliori medici di Radioterapia - TOP-95medici

Nichakorn Seehirunwong, M.D.

Radiologist

Graduated (M.D. From)

Doctor of Medicine, Faculty of Medicine, Prince of Songkla University

• Interpreting the results of medical imaging tests.
• Comparing medical image findings with other examinations and tests.
• Consulting with your referring healthcare provider (the provider who ordered the imaging tests) to help choose the proper imaging test and using test results to inform your medical care. Writing reports of results and diagnoses.
• Recommending additional examinations or treatments when necessary.
• Treating diseases by using radiation (radiation oncology) or imaging-guided procedures (interventional radiology). Performing or directing radiology staff to carry out imaging tests.

Certificates

Certificate of Diagnostic Radiology, Faculty of Medicine, Prince of Songkla University

Current Positions

Diagnostic Radiologist at Intrarat Hospital

Il medico è un oncologo specializzato nel trattamento dei tumori al seno, ai polmoni e gastrointestinali. Attualmente, il medico pratica presso l'Ospedale Universitario Istinye Liv.

Con una carriera che si estende su molteplici istituzioni prestigiose, il medico ha servito come Specialista in Medicina Interna presso l'Ospedale Statale di Malatya, medico presso la Clinica Oncologica di Ankara e membro del Dipartimento di Oncologia presso l'Ospedale Regionale di Formazione e Ricerca di Erzurum.

Il medico si è laureato presso la Facoltà di Medicina dell'Università di Selcuk e ha ottenuto il titolo di Professore Associato nel 2016.

Education and Specialization

• 2006: Kocaeli University Faculty of Medicine
• 2014: Akdeniz University Faculty of Medicine, Internal Medicine
• 2018: Akdeniz University Faculty of Medicine, Medical Oncology

Experience

• 2006 - 2008: Konya Derebucak District Hospital
• 2009 - 2015: Akdeniz University Hospital
• 2015: Antalya Kaş State Hospital
• 2015 - 2016: İnönü University Faculty of Medicine
• 2016 - 2021: Akdeniz University Hospital
• 2021 - 2023: Antalya Training and Research Hospital

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Il medico è un oncologo medico e radioterapista con 33 anni di esperienza, specializzato in oncologia e radioterapia. Si è laureato presso l'Ospedale Universitario Hadassah a Gerusalemme, Israele, e possiede qualifiche in oncologia e radioterapia.<\/p>

Attualmente è il capo del Centro per il Cancro Gastrointestinale ed è anche un medico senior nel Dipartimento di Oncologia dell'Ospedale Universitario Hadassah. Ha completato gli esami di certificazione in oncologia e radioterapia ed è membro di diverse società professionali, tra cui la Società Israeliana di Oncologia Clinica e l'Associazione Israeliana per il Cancro.<\/p>

Il medico si è laureato presso la Facoltà di Medicina dell'Università Ebraica nel 1987 e si specializza in Chirurgia e Chirurgia Colorettale. Affiliato al Centro Medico Hadassah, il medico è Istruttore in Chirurgia dal 1995, Docente dal 1999 e Docente Senior dal 2005. Il medico dirige il Programma per Studenti di Medicina nel Dipartimento di Chirurgia dal 1997 ed è Direttore del Programma di Residenza nel Dipartimento di Chirurgia dal 2000. Certificato in Chirurgia Generale in Israele dal 1998, il medico è anche membro di varie associazioni chirurgiche.<\/p>

Il medico è uno specialista altamente qualificato in Oncologia Pediatrica e Emato-Oncologia presso il Centro Medico Hadassah, riconosciuto nella lista Forbes dei migliori medici in Israele 2019-2020. Con oltre vent'anni di specializzazione in pediatria, emato-oncologia pediatrica e trapianto di midollo osseo aploidente, il medico è una figura di spicco nel campo.<\/p>

Il medico è laureato all'Università di Tel Aviv e partecipa attivamente ad associazioni professionali tra cui la Società Israeliana di Ematologia e Oncologia Pediatrica, l'Associazione Israeliana del Cancro, l'Associazione Internazionale di Oncologia e la Società Internazionale di Oncologia Pediatrica. I principali campi di interesse includono il retinoblastoma, la medicina di precisione e l'oncologia pediatrica.<\/p>

Il medico è un cardiologo interventista esperto con oltre 25 anni di esperienza presso il Samsung Medical Center. Specializzandosi in chirurgia cardiaca, il medico si concentra su trapianti di cuore, chirurgia delle arterie coronarie, riparazione e sostituzione delle valvole, chirurgia cardiaca pediatrica e chirurgia cardiaca assistita da robot. Il medico ha conseguito lauree presso l'Università della California, San Diego, e l'Università della Carolina del Nord, Chapel Hill.<\/p>

Il medico è uno specialista in radioterapia con molta esperienza, con oltre 15 anni nel campo, concentrandosi su tecniche avanzate di trattamento del cancro. Il medico ha trattato con successo migliaia di pazienti utilizzando tecnologie di terapia radiante all'avanguardia, tra cui IMRT e radiochirurgia stereotassica. Il medico è certificato in oncologia radioterapica e ha pubblicato numerosi articoli di ricerca su metodi innovativi di radioterapia. Il medico è attivamente coinvolto in studi clinici mirati a migliorare i risultati dei pazienti ed è membro di diverse società oncologiche prestigiose.<\/p>

Il medico è il capo del Dipartimento di Oncologia Radioterapica e ha una vasta esperienza in oncologia, avendo completato la formazione specialistica presso il Samsung Medical Center e l'Ospedale dell'Università Nazionale di Seoul. Il medico si è laureato presso il College of Medicine dell'Università Nazionale di Seoul e si specializza nel trattamento del cancro allo stomaco, del cancro pancreatobiliare, dei tumori del SNC, dei tumori pediatrici, dei sarcomi e dei tumori ematologici.<\/p>

Core Specializations

Oncology:

Head and neck tumors

Thyroid cancer

Personalized biological and immunotherapy

Treatment of recurrent cancer and spinal metastases

Radiotherapy

Education

1998 — Graduated from the Faculty of Medicine at the Hebrew University (Jerusalem, Israel).
2016 — Six-month advanced training course in radiosurgery with a special focus on modern methods of focused radiotherapy for spinal and malignant thyroid tumors at Memorial Sloan Kettering Cancer Center (New York, USA).

Professional Experience

1998–1999 — Internship at Hadassah University Hospital (Jerusalem, Israel).
1999–2005 — Specialization in the Department of Otolaryngology and Head & Neck Surgery at Rabin Medical Center (Petah Tikva, Israel).
2005–2009 — Specialization in oncology and radiotherapy at the Davidoff Cancer Center (Rabin Medical Center).
2006–2008 — Fellowship at the University of Michigan (Ann Arbor, USA) in multidisciplinary cancer treatment.
2008 — Fellowship in head and neck tumor brachytherapy at Beth Israel Medical Center (New York, USA).
2009–2012 — Head of the Head and Neck Oncology Clinic at the Davidoff Cancer Center.
2013–2019 — Chief of the Head and Neck Oncology Division and Deputy Head of the Radiotherapy Department at the Davidoff Cancer Center.
Since 2019 — Director of the Oncology Department and Sharett Cancer Institute at Hadassah University Hospital.

Il medico è direttore della divisione pediatrica presso l'Ospedale Pediatrico Ruth Rappaport (Rambam) ed è un esperto riconosciuto a livello mondiale in oncologia pediatrica e trapianto di midollo osseo.<\/p>

Riconosciuto per i contributi eccezionali nel campo, il medico ha ricevuto il Premio del Ministero della Salute e il titolo di Cavaliere della Legion d'Onore in Francia. Inoltre, è stato riconosciuto dall'Associazione Medica Mondiale come uno dei medici più premurosi al mondo.<\/p>

Attivo nelle comunità mediche internazionali, il medico è membro del gruppo di oncologia pediatrica negli USA e di varie società europee di oncologia.<\/p>

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Lucía González Cortijo is a medical oncologist with more than 20 years of experience. She has led the Medical Oncology Department at Hospital Universitario Quirónsalud Madrid since 2020. Her focus areas include breast and gynecologic cancers. She also works in precision oncology, targeted therapies, and immunotherapy.

She has been Principal Investigator in more than 20 Phase II–III clinical trials. She has also served as sub-investigator in over 50 international trials. She previously worked at Quirónsalud Madrid from 2009 to 2020. Before that, she was at MD Anderson Cancer Center Madrid from 2002 to 2009.

She holds an MD and a PhD (cum laude) from the Autonomous University of Madrid. She completed her Medical Oncology specialty training at Hospital 12 de Octubre. She also earned a Master’s in Molecular Oncology. She is a member of SEOM, ESMO, ASCO, and GEICAM. She is a university lecturer.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Il medico è un oncologo e radiologo altamente esperto, specializzato nella diagnosi e nel trattamento del cancro. Con un focus su tecniche di imaging avanzate e terapie personalizzate per il cancro, il medico ha contribuito significativamente al campo sia attraverso la pratica clinica che la ricerca. Il medico ha partecipato a numerosi studi clinici volti a migliorare i risultati dei pazienti e ha pubblicato ampiamente su riviste mediche peer-reviewed. Il medico è certificato in oncologia e radiologia, dimostrando un impegno a mantenere i più alti standard di assistenza medica.<\/p>

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.